Tavneos’ original developer hid a study analysis and then altered data, the FDA alleged. Elsewhere, Erasca’s RAS drug was met with skepticism and Rocket Pharma sold a voucher.
The American Hospital Association (AHA) writes to alert you to the latest development in connection with the growing number ...
From holiday wish lists to mounting sale statistics, the rise of tablet PCs is impossible to ignore. Citing new Gartner findings, GigaOm notes that tablet fever is cutting into PC sales. According to ...
The problem with monthly data plans for tablets is that you might end up paying for service you don’t use. So AT&T is trying a different approach, where users can buy short-term data plans instead. As ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results